Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

被引:3
|
作者
Bartziokas, Konstantinos [1 ,2 ]
Papathanasiou, Evgenia [2 ]
Papaioannou, Andriana I. I. [2 ]
Papanikolaou, Ilias [3 ]
Antonakis, Emmanouil [3 ]
Makou, Ioanna [3 ]
Hillas, Georgios [4 ]
Karampitsakos, Theodoros [4 ]
Papaioannou, Ourania [4 ]
Dimakou, Katerina [4 ]
Apollonatou, Vasiliki [2 ]
Verykokou, Galateia [2 ]
Papiris, Spyros [2 ]
Bakakos, Petros [5 ]
Loukides, Stelios [2 ]
Kostikas, Konstantinos [1 ]
机构
[1] Univ Ioannina, Resp Med Dept, Ioannina 45110, Greece
[2] Natl & Kapodistrian Univ Athens, Resp Med Dept 2, Athens 10679, Greece
[3] Corfu Gen Hosp, Resp Med Dept, Corfu 49100, Greece
[4] Sotiria Chest Hosp, Resp Med Dept 5, Athens 11527, Greece
[5] Natl & Kapodistrian Univ Athens, Resp Med Dept 1, Athens 10676, Greece
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 04期
关键词
COPD; exacerbations; eosinophils; hospital admission; non-invasive ventilation; OBSTRUCTIVE PULMONARY-DISEASE; HOSPITALIZED EXACERBATIONS; MECHANICAL VENTILATION; BLOOD EOSINOPHILS; INFECTION; OUTCOMES;
D O I
10.3390/jpm13040686
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of adverse outcomes. Objectives: The aim of the present post hoc analysis was to elucidate the effectiveness of blood eosinophils for predicting the need of NIV in subjects with COPD exacerbation. Methods: Consecutive subjects admitted to a hospital for COPD exacerbation were included in the analysis. The eosinophil count from the first complete blood count was used to designate the eosinophil groups. The relationship between the clinical characteristics and blood eosinophil counts, as dichotomized using 150 cells/mu L, was evaluated. Results Subjects with blood eosinophil number < 150 k/mu L had a more severe disease on admission compared to subjects with >= 150 k/mu L, regarding pH 7.400 (7.36, 7.44) vs. 7.42 (7.38, 7.45), p = 0.008, PO2/FiO(2) levels 238.1 (189.8, 278.6) vs. 276.2 (238.2, 305.6), p < 0.001, CRP (mg/L) levels 7.3 (3.1, 19.9) vs. 3.5 (0.7, 7.8), p < 0.001 and required a longer hospital stay (days) 10.0 (8.0, 14.0) vs. 5.0 (3.0, 7.0) p < 0.001 respectively. The number of blood eosinophils correlated with the levels of CRP upon admission (p < 0.001, r = -0.334), with arterial pH upon admission (p < 0.030, r = 0.121), with PO2/FiO(2) (p < 0.001, r = -0.248), and with duration of hospital stay (p < 0.001, r = -0.589). In the multinomial logistic regression analysis, blood eosinophil count < 150 k/mu L was an independent predictor of the use of NIV during hospital stay. Conclusion: During COPD exacerbation, low blood eosinophil levels upon admission are related to more severe disease and can be used as a predictor of the need of NIV. Further prospective studies are needed to identify the use of blood eosinophil levels as a predictor of unfavorable outcomes.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Home noninvasive ventilation in COPD
    Cheung, A. P. S.
    Chan, V. L.
    Chu, C-M.
    BREATHE, 2010, 6 (03) : 260 - 266
  • [22] Home Noninvasive Ventilation for COPD
    Orr, Jeremy E.
    RESPIRATORY CARE, 2023, 68 (07) : 1013 - 1022
  • [23] NONINVASIVE VENTILATION FOR PATIENTS WITH COPD
    Suh, Hee Jung
    RESPIROLOGY, 2017, 22 : 7 - 7
  • [24] The Ideal Biomarker To Predict COPD Exacerbations
    Zafari, Z.
    Sin, D. D.
    Bryan, S.
    Sadatsafavi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [25] The Potential of Procalcitonin as a Biomarker in Exacerbations of COPD
    Rodriguez, Moises
    Varon, Joseph
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2023, 19 (02) : 83 - 84
  • [26] Pulmonary hypertension: a prognostic factor for response to non invasive mechanical ventilation in COPD exacerbations
    Petroianni, A.
    Parola, D.
    Terzano, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (08) : 1135 - 1136
  • [27] Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD (vol 15, pg 1259, 2022)
    Wei, T.
    Wang, X.
    Lang, K.
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 1993 - 1993
  • [28] Exacerbations between COPD patients with and without comorbid bronchiectasis treated with noninvasive mechanical ventilation- are there differences?
    Serino, Mariana
    Freitas, Claudia
    Van Zeller, Mafalda
    Pinto, Tiago
    Lourenco, Patricia
    Goncalves, Miguel
    Drummond, Marta
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] THE USE OF NONINVASIVE MECHANICAL VENTILATION IN COPD PATIENTS WITH SEVERE HYPERCAPNIC ACIDOSIS
    Cimen, P.
    Kirakli, C.
    Edipoglu, O.
    Bilaceroglu, S.
    Cirak, K. A.
    Halilcolar, H.
    INTENSIVE CARE MEDICINE, 2009, 35 : 127 - 127
  • [30] MULTIDIMENSIONAL PROGNOSTIC INDEX FOR EXACERBATIONS OF COPD
    Short, P. M.
    Williamson, P. A.
    Singanayagam, A.
    Akram, A.
    Schembri, S.
    Chalmers, J. D.
    THORAX, 2013, 68 : A137 - A138